"Since 2006, we're dedicated to conduct FDA regulated clinical trials for over 30 different health conditions. Our services have been contracted by more than 20 of the leading pharmaceutical companies to participate in large-scale and fast track trials. We are located just 1 mile away from Miami International Airport, right across the Doubletree Miami Mart / Exhibition Center, just a short drive to Miami Beach, Downtown Miami, Brickell Avenue and Coral Gables. Insurance, medicare or your PCP referral are not required to participate. Call us to learn more about our studies!"

During the past decade, Pharmax Research Clinic, Inc. conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 31 clinical trials were completed, i.e. on average, 129.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 17 clinical trials were completed. i.e. 154.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharmax Research Clinic, Inc." #1 sponsor was "Pfizer" with 10 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored and "Janssen Vaccines & Prevention B.V." with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmax Research Clinic, Inc." #1 collaborator was "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "The Cleveland Clinic" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Pharmax Research Clinic, Inc." are "Alzheimer's Disease" (4 trials), "Depressive Disorder, Major" (4 trials), "Osteoarthritis" (4 trials), "Type 2 Diabetes" (4 trials) and "Cardiovascular Disease" (3 trials). Many other conditions were trialed in "Pharmax Research Clinic, Inc." in a lesser frequency.

Most popular intervention types in "Pharmax Research Clinic, Inc." are "Drug" (44 trials), "Biological" (12 trials), "Other" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "tanezumab" (4 trials), "Aticaprant" (2 trials), "Bapineuzumab 0.5 mg/kg" (2 trials) and "Bapineuzumab 1.0 m/kg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pharmax Research Clinic, Inc." are 53 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Pharmax Research Clinic, Inc.". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Pharmax Research Clinic, Inc., undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Pharmax Research Clinic, Inc., 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 0 trials that are defined as “Not Applicable".